150 related articles for article (PubMed ID: 1546712)
1. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.
Shimazaki C; Gotoh H; Ashihara E; Oku N; Inaba T; Murakami S; Itoh K; Ura Y; Nakagawa M; Fujita N
Am J Hematol; 1992 Mar; 39(3):159-62. PubMed ID: 1546712
[TBL] [Abstract][Full Text] [Related]
2. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
García-Sanz R; Orfão A; González M; Tabernero MD; Bladé J; Moro MJ; Fernández-Calvo J; Sanz MA; Pérez-Simón JA; Rasillo A; Miguel JF
Blood; 1999 Feb; 93(3):1032-7. PubMed ID: 9920853
[TBL] [Abstract][Full Text] [Related]
3. Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
Greipp PR; Trendle MC; Leong T; Oken MM; Kay NE; Van Ness B; Kyle RA
Leuk Lymphoma; 1999 Sep; 35(1-2):83-9. PubMed ID: 10512165
[TBL] [Abstract][Full Text] [Related]
4. Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia.
Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Sugimoto Y; Kaihara C; Matsuzaki M; Hoshi Y; DeCaprio JA; Anderson KC
Clin Cancer Res; 1997 Nov; 3(11):2173-9. PubMed ID: 9815612
[TBL] [Abstract][Full Text] [Related]
5. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
7. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation.
Jonveaux P; Berger R
Genes Chromosomes Cancer; 1992 Jun; 4(4):321-5. PubMed ID: 1377939
[TBL] [Abstract][Full Text] [Related]
8. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.
Van Wier S; Braggio E; Baker A; Ahmann G; Levy J; Carpten JD; Fonseca R
Haematologica; 2013 Oct; 98(10):1586-92. PubMed ID: 23716545
[TBL] [Abstract][Full Text] [Related]
9. The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience.
López-Otero A; Ruiz-Delgado GJ; Hernández-Arizpe A; Ruiz-Argüelles A; Ruiz-Argüelles GJ
Hematology; 2010 Dec; 15(6):378-81. PubMed ID: 21114899
[TBL] [Abstract][Full Text] [Related]
10. Analysis of G banded karyotypes in myeloma cells.
Chen KC; Bevan PC; Matthews JG
J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell leukemia.
Albarracin F; Fonseca R
Blood Rev; 2011 May; 25(3):107-12. PubMed ID: 21295388
[TBL] [Abstract][Full Text] [Related]
13. Plasma cell leukaemia mimicking acute monocytic leukaemia in the course of multiple myeloma.
Eclache V; Lusina D; Lejeune F; Casassus P; Smadja N; Lortholary P
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):419-22. PubMed ID: 8414961
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotype and DNA cell content in multiple myeloma.
San Miguel JF; Garcia-Sanz R; Gonzalez M; Orfao A
Baillieres Clin Haematol; 1995 Dec; 8(4):735-59. PubMed ID: 8845570
[TBL] [Abstract][Full Text] [Related]
15. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization.
Gutiérrez NC; Hernández JM; García JL; Cañizo MC; González M; Hernández J; González MB; Garciá-Marcos MA; San Miguel JF
Leukemia; 2001 May; 15(5):840-5. PubMed ID: 11368447
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell leukemia: a report on 15 patients.
Bernasconi C; Castelli G; Pagnucco G; Brusamolino E
Eur J Haematol Suppl; 1989; 51():76-83. PubMed ID: 2697596
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.
Gutensohn K; Weh HJ; Walter TA; Hossfeld DK
Ann Hematol; 1992 Aug; 65(2):88-90. PubMed ID: 1511063
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Shimazaki C; Fried J; Perez AG; Scheinberg DA; Atzpodien J; Wang CY; Wisniewolski R; Clarkson BD
Acta Haematol; 1990; 83(3):123-9. PubMed ID: 2109450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
